Search
Skye Bioscience Inc
SKYEAdd to Watchlist
1.090USD
+0.010+0.93%
Close 11-13 16:00（ET）
4.83MMarket Cap
LossP/E TTM
Skye Bioscience Inc (SKYE) Stock Price Target & Forecast
Analyst Rating
Based on 4 analysts giving stock ratings to Skye Bioscience Inc in the past month.
Buy
0 Strong Buy
2 Buy
2 Hold
0 Sell
0 Strong Sell
Target Price
16.000USD+824.86%
SKYE Analyst Recommendation Trends
In the current month, SKYE has received 2 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. SKYE average Analyst price target in the last month is 16.000.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
0
0
1
2
2
2
2
2
2
2
4
4
4
4
4
4
2
2
2
2
2
2
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4
4
7
8
8
8
8
8
SKYE Analyst Rating for Peer Comparison
Updated: Nov 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
argenx SE
ARGX
10
14
3
0
0
27
Beigene Ltd
ONC
8
19
0
0
0
27
Ionis Pharmaceuticals Inc
IONS
6
16
4
0
0
26
Insmed Inc
INSM
6
18
1
0
0
25
Revolution Medicines Inc
RVMD
10
14
1
0
0
25
Ascendis Pharma A/S
ASND
9
13
1
0
0
23
CRISPR Therapeutics AG
CRSP
4
8
11
0
0
23
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
Tempus AI Inc
TEM
4
7
11
0
1
23
Biontech SE
BNTX
4
12
6
0
0
22
Financial Forecasting
Based on analysts' estimates, SKYE EPS is projected to reach -1.520 in FY2026Q4, following reported EPS of 0.014 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
FY2027Q1
Forecast
-2.47
-1.97
-1.58
-1.52
-1.60
Actual
-0.32
-2.17
0.01
--
--
Surprise
+87.25%
-10.08%
+100.88%
--
--
FAQs
What is Skye Bioscience Inc's price target?
Analysts forecast that Skye Bioscience Inc's price target is USD 16.00, with the highest forecast at USD 16.00 and the lowest forecast at USD 16.00.
How have Skye Bioscience IncSKYE's recent earnings per share performed?
The market expectation was USD 0.01, while Skye Bioscience IncSKYE's earnings per share (EPS) for the previous quarter was USD -2.17. EPS for the next quarter is expected at USD -1.52.
What is the analyst rating for Skye Bioscience Inc?
Based on the ratings of Skye Bioscience Inc's stock from 4 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.